DaVita DVA · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
185.54
-3.04%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$13.64bn
FY2016FY2025
Net income
$746.8m
FY2016FY2025
Free cash flow
$1.31bn
FY2016FY2025
Shareholders' equity
$1.16bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64bn | $12.82bn | $12.14bn | $11.61bn | $11.62bn | $11.55bn | $11.39bn | $11.40bn | $10.88bn | $14.75bn |
| Gross profit | $3.68bn | $4.22bn | $3.82bn | $3.40bn | $3.65bn | $3.56bn | $3.47bn | $3.21bn | $3.24bn | $3.28bn |
| Operating income | $2.01bn | $2.09bn | $1.60bn | $1.32bn | $1.80bn | $1.69bn | $1.64bn | $1.53bn | $1.81bn | $2.03bn |
| Net income | $746.8m | $936.3m | $691.5m | $560.4m | $978.5m | $773.6m | $811.0m | $159.4m | $663.6m | $879.9m |
| Diluted earnings per share | 8.48 | 10.91 | 7.45 | 6.10 | 9.33 | 6.67 | 6.21 | 0.96 | 3.59 | 4.47 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $17.48bn | $17.29bn | $16.89bn | $16.93bn | $17.12bn | $16.99bn | $17.31bn | $19.11bn | $18.95bn | $18.74bn |
| Cash and short-term investments | $782.0m | $846.0m | $391.7m | $321.8m | $484.2m | $345.1m | $1.11bn | $326.0m | $551.8m | $1.22bn |
| Total liabilities | $16.32bn | $15.19bn | $14.15bn | $14.70bn | $14.75bn | $14.09bn | $13.81bn | $14.08bn | $13.05bn | $12.92bn |
| Debt | $10.27bn | $9.45bn | $8.39bn | $8.92bn | $8.91bn | $8.09bn | $8.11bn | $10.10bn | $9.34bn | $9.11bn |
| Shareholders' equity | $1.16bn | $2.09bn | $2.74bn | $2.22bn | $2.37bn | $2.90bn | $3.50bn | $5.03bn | $5.90bn | $5.82bn |
| Shares outstanding | 88m | 86m | 93m | 92m | 105m | 116m | 131m | 166m | 185m | 197m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $1.89bn | $2.02bn | $2.06bn | $1.56bn | $1.93bn | $1.98bn | $2.07bn | $1.77bn | $1.91bn | $1.96bn |
| Capital spending | −$575.9m | −$555.4m | −$568.0m | −$603.4m | −$641.5m | −$674.5m | −$766.5m | −$987.1m | −$905.3m | −$829.1m |
| Free cash flow | $1.31bn | $1.47bn | $1.49bn | $961.1m | $1.29bn | $1.30bn | $1.31bn | $784.5m | $1.00bn | $1.13bn |
| Dividends paid | — | — | — | −$267.9m | −$244.0m | −$253.1m | −$11.4m | −$196.4m | −$211.5m | −$192.4m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55bn | $3.42bn | $3.62bn | $3.42bn | $3.38bn | $3.22bn | $3.29bn | $3.26bn |
| Gross profit | $1.16bn | $1.07bn | $1.02bn | $1.09bn | $1.12bn | $983.9m | $1.07bn | $1.11bn |
| Operating income | $570.8m | $481.9m | $551.2m | $505.8m | $537.8m | $438.9m | $565.4m | $534.9m |
| Net income | $265.4m | $197.5m | $234.2m | $150.3m | $199.3m | $162.9m | $259.3m | $214.7m |
| Diluted earnings per share | 4.02 | 2.99 | 2.66 | 1.71 | 2.26 | 1.85 | 3.02 | 2.50 |
| Cash from operations | $490.0m | $320.0m | $540.0m | $841.0m | $324.0m | $180.0m | $547.0m | $810.0m |
| Capital spending | −$169.0m | −$102.0m | −$145.0m | −$166.0m | −$121.0m | −$143.0m | −$170.0m | −$139.0m |
| Free cash flow | $321.0m | $218.0m | $395.0m | $675.0m | $203.0m | $37.0m | $377.0m | $671.0m |
| Total assets | $17.71bn | $17.50bn | $17.48bn | $17.74bn | $17.49bn | $17.12bn | $17.29bn | $17.50bn |
| Cash and short-term investments | $688.9m | $748.7m | $782.0m | $736.5m | $739.4m | $511.9m | $846.0m | $1.09bn |
| Debt | $10.78bn | $11.06bn | $12.87bn | $12.78bn | $12.82bn | $12.32bn | $12.07bn | $12.20bn |
| Shareholders' equity | −$765.1m | −$755.5m | $1.16bn | $1.53bn | $1.55bn | $1.66bn | $2.09bn | $2.22bn |
Financial ratios
Data as of 6 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 27.0% | 32.9% | 31.5% | 29.3% | 31.4% | 30.8% |
| Operating margin | 14.1% | 15.6% | 13.0% | 11.4% | 15.5% | 14.0% |
| Net margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% |
| Return on equity | 64.5% | 44.8% | 25.2% | 25.2% | 41.3% | 26.7% |
| Return on assets | 4.3% | 5.4% | 4.1% | 3.3% | 5.7% | 4.6% |
| Free cash flow yield | 15.6% | 16.8% | 15.8% | 13.2% | 13.7% | 12.8% |
| Revenue growth | 6.5% | 5.6% | 4.6% | -0.1% | 0.6% | 1.4% |
| Earnings growth | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | -4.6% |
| Current ratio | 1.29x | 1.26x | 1.19x | 1.20x | 1.32x | 1.27x |
| Debt to equity | 9.24x | 4.71x | 3.20x | 4.19x | 3.92x | 2.92x |
| Equity ratio | 6.6% | 12.1% | 16.2% | 13.1% | 13.8% | 17.1% |
| Interest coverage | 3.51x | 4.25x | 3.95x | 3.71x | 6.32x | 5.33x |
| Buybacks as a share of market value | -2.7% | 7.5% | -0.9% | 12.3% | 9.6% | 11.1% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 5.5% | 3.4% | -0.1% |
| Operating income | 15.0% | 3.5% | 5.9% |
| Net income | 10.0% | -0.7% | 10.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 29.9% | 30.1% | 30.4% | 28.5% |
| Operating margin | 15.5% | 14.0% | 14.3% | 13.8% |
| Net margin | 6.4% | 5.8% | 6.4% | 5.5% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 13.4 | 13.7 | 14.1 | 12.3 | 12.2 | 17.6 | 12.1 | 53.8 | 20.1 | 14.4 |
| Price to sales | 0.7 | 1.0 | 0.8 | 0.6 | 1.0 | 1.2 | 0.9 | 0.8 | 1.2 | 0.9 |
Market value over time
30 Nov 2016 to 5 Oct 2026, in USD
$13.11bn$11.81bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -21% | 38% | 47% | -32% | -8% | 57% | 44% | -29% | 11% | -6% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 2-for-1 split · 9 Sept 2013
- 3-for-2 split · 16 Jun 2004
- 5-for-3 split · 21 Oct 1997
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.